We’re excited to announce the appointment of Jesse Smith as NextRNA’s Chief Scientific Officer! With his deep expertise in pioneering first-in-class targeted small molecule therapies, Dr. Smith is ideally suited to lead our scientific organization. At NextRNA we are focused on inhibiting the function of disease-driving lncRNAs with small molecules. With our unique platform and capabilities, we have the potential to address multiple high unmet diseases and deliver transformative medicines for patients. Welcome to the NextRNA team, Jesse! Read press release: https://bit.ly/4eiFGUD #RNA #smallmolecule #drugdiscovery #drugdevelopment #lncRNA #darkgenome
NextRNA Therapeutics
Biotechnology Research
Boston, Massachusetts 6,699 followers
Leading The Next Revolution of RNA-directed Therapeutics
About us
NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs) with small molecules in oncology and neuroscience. Our proprietary computational engine, combined with deep lncRNA biology expertise and strong drug discovery capabilities, positions us well to unlock the therapeutic value of lncRNAs, a vast and promising target space. NextRNA has assembled an experienced team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
- Website
-
http://NextRNATx.com
External link for NextRNA Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
40 Guest St
Boston, Massachusetts 02135, US
Employees at NextRNA Therapeutics
Updates
-
Our Co-Founder & CEO, Dominique Verhelle, will give a corporate presentation on Monday, Sep. 30th at 1:30 pm ET at Chardan’s 8th Annual Genetic Medicines Conference in NYC. There is increasing evidence that lncRNAs are implicated in the pathogenesis of a broad spectrum of diseases. With our unique platform and capabilities, NextRNA is well positioned to discover new lncRNA targets and develop transformative small molecule medicines for patients. We look forward to discussing our progress as a leader in the rapidly emerging lncRNA space at #ChardanGMConf! #RNA #smallmolecule #lncRNA #darkgenome
-
At NextRNA, we believe in the power of community and the importance of supporting and empowering women. Recently, a group of our amazing employees had the honor of volunteering at Rosie's Place, a sanctuary for poor and homeless women in Boston. Together, we served meals, provided support, and contributed to an incredible organization that uplifts women every day. 💪 When we empower women, we strengthen our community and fuel a brighter future for everyone. Thank you, Rosie’s Place, for the vital work you do, and thank you to our volunteers for making an impact! #EmpoweringWomen #VolunteerWork #Community #CompanyValues #RosiesPlace #WomenSupportingWomen #GivingBack
-
💼 Exciting Opportunity: Director of Finance/Controller Role We're searching for a Director of Finance/Controller to lead our finance operations, driving strategic financial planning and execution. We’re looking for someone who can not only manage numbers but also inspire others and champion a culture of transparency and excellence. If this sounds like you or someone you know, we’d love to connect! Please feel free to reach out or share this opportunity with your network. #FinanceLeadership #ControllerRole #FinanceJobs #LeadershipOpportunity
-
Thank you, Labiotech.eu, for speaking with our CEO and Co-Founder Dominique Verhelle about what lncRNAs are, the key role they play across numerous diseases, and the increasing interest in lncRNAs as a therapeutic target class. Read article: https://lnkd.in/gRH-PC_J
-
Last week, we announced a strategic collaboration with Bayer to develop small molecules targeting long non-coding RNAs (lncRNAs) in oncology. With our Bayer colleagues, we’ll jointly advance two first-in-class, lncRNA-targeted oncology programs in high unmet need indications. Our differentiated approach – which involves inhibiting the function of lncRNAs by disrupting the interaction between lncRNAs and RNA-binding proteins with small molecules – can be leveraged across many therapeutic areas, including oncology and neuroscience, among others. We look forward to working closely with Bayer while continuing to build our internal pipeline and forge strategic partnerships to maximize the broad potential of the lncRNA target class. Read the press release: https://bit.ly/3Xm0q7O #lncRNA #RNA #smallmolecules #darkgenome #oncology #cancer #neuroscience
-
We’re delighted to announce that NextRNA has entered into a strategic collaboration with Bayer to develop small molecules targeting long non-coding RNAs (lncRNAs) in oncology. lncRNAs represent a vast class of therapeutic targets that recruit RNA-binding proteins (RBPs) to drive pathological processes across diseases. NextRNA’s unique focus on disrupting lncRNA-RBP interactions with small molecules represents an innovative approach to develop a new class of therapeutic agents in oncology, neuroscience, and many other therapeutic areas. With Bayer we’ll jointly advance two first-in-class, lncRNA-targeted oncology programs in high unmet need indications. This marks a transformative milestone for the lncRNA target class and for NextRNA as we work to bring novel small molecule medicines to patients by realizing the potential of lncRNAs! Read the press release: https://bit.ly/3Xm0q7O #lncRNA #RNA #smallmolecules #darkgenome #oncology #cancer
-
We're #hiring a new Director/Senior Director, Alliance & Program Management in Boston, Massachusetts. Apply today or share this post with your network.
-
🚀 We're Hiring! 🚀 If you’re ready to make a significant impact in RNA-directed therapeutics and thrive in a dynamic, collaborative setting, we’d love to connect with you! #RNAtherapeutics #Biotech #TargetIdentification #Hiring #Scientist #CareerOpportunity #Innovation #MolecularBiology #Genetics #DrugDiscovery